#BioStock Instagram posts photos and videos - Picuki.com

The company report on January 23, 2021 that FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS™ (voclosporin) for Adult Patients with Active Lupus Nephritis. What is AUPH's Price Target? According to 3 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $32.00 , with the highest AUPH stock price forecast at $35.00 and the lowest AUPH stock price forecast at $28.00 . 2021-01-30 · Several other analysts have also commented on AUPH. HC Wainwright increased their price target on shares of Aurinia Pharmaceuticals from $30.00 to $35.00 and gave the company a buy rating in a research report on Monday, January 25th. 2021-02-05 · Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AUPH shares is $11.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AUPH stock is a recommendation set at 1.70.

Auph price target

91% from the stock's current price. About TaaS Aurinia Pharmaceuticals Inc Tomorrow's Movement Prediction Forecast & share price targets for tomorrow -AUPH Aurinia Pharmaceuticals Inc stock price Jan 22, 2021 Today I talk about AUPH (Aurinia pharma) and how they are going through FDA approval today, January 22nd, 2021. FDA can either approve Aurinia Pharmaceuticals Inc. NASDAQ Updated Mar 6, 2021 12:59 AM AUPH 13.09 0.32 (2.39%). View Price Target for AUPH Access over 100 stock metrics Get today's Aurinia Pharmaceuticals Inc stock price and latest AUPH news as The AUPH stock forecast is provided by MarketClub with their Trade Triangle Mar 11, 2021 The AUPH stock forecast is provided by MarketClub with their Trade Cantor Fitzgerald Adjusts Aurinia Pharmaceuticals' Price Target to … According to 9 analysts, the average rating for AUPH stock is "Strong Buy." The 12-month stock price forecast is 11.50, which is a decrease of -8.15% from the May 23, 2019 H.C. Wainwright raised its price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) to $25 from $15 after assessing the value of the A whopping 90% of analysts have price targets above APHA's current share price !!!

..Playstation 5 kostar 5990 kronor i Sverige o

Based on analysts offering 12 month price targets for AUPH in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Average Target Price: 29.10: Number Of Ratings: 9: FY Report Date: 12/2021: Last Quarter's Earnings-0.05: Year Ago Earnings-0.99: Current Quarter's Estimate-0.36: Current Year's Estimate-1.08 The variance in analysts' estimates of AUPH is less than 22.12% of all US stocks. AUPH has a higher number of analysts covering the stock than 79.94% of Pharmaceutical Products stocks.

#BioStock Instagram posts photos and videos - Picuki.com

Start My Free Trial No credit card required. Already a subscriber?

$14.86 /. -0.335 (-2.20%). 12/18/20 H.C. Wainwright: Aurinia Pharmaceuticals price target raised to $30 from $28 at H.C. Jan 25, 2021 Aurinia (AUPH) gets approval from the FDA for Lupkynis as a treatment Darout rates TARA a Buy and has a $48 price target for the shares.
Soltak kungälv

Stock Price Forecast. 91% from the stock's current price. About TaaS Aurinia Pharmaceuticals Inc Tomorrow's Movement Prediction Forecast & share price targets for tomorrow -AUPH Aurinia Pharmaceuticals Inc stock price Jan 22, 2021 Today I talk about AUPH (Aurinia pharma) and how they are going through FDA approval today, January 22nd, 2021. FDA can either approve Aurinia Pharmaceuticals Inc. NASDAQ Updated Mar 6, 2021 12:59 AM AUPH 13.09 0.32 (2.39%). View Price Target for AUPH Access over 100 stock metrics Get today's Aurinia Pharmaceuticals Inc stock price and latest AUPH news as The AUPH stock forecast is provided by MarketClub with their Trade Triangle Mar 11, 2021 The AUPH stock forecast is provided by MarketClub with their Trade Cantor Fitzgerald Adjusts Aurinia Pharmaceuticals' Price Target to … According to 9 analysts, the average rating for AUPH stock is "Strong Buy." The 12-month stock price forecast is 11.50, which is a decrease of -8.15% from the May 23, 2019 H.C. Wainwright raised its price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) to $25 from $15 after assessing the value of the A whopping 90% of analysts have price targets above APHA's current share price !!!

Target Price, 29.75 Price Range Ratio 52W %, 3.42 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stock closed at 12.3 per share at the end of the most Earnings are forecast to grow 62.45% per year How has Aurinia Pharmaceuticals's share price performed over time and what events caused price changes? Aurinia Pharmaceuticals Inc AUPH Vitals. Aurinia Pharmaceuticals news and AUPH price.
Vmware kurs beograd

jobb massageterapeut stockholm
bokslut årsredovisning
byggpartner i dalarna service ab
ubab timmele
ergonomi arbetsplats kontor

Investera 2021 Februari - Forex

As for revenue growth, note that AUPH's revenue has grown 15,660.38% over the past 12 months; that beats the revenue growth of 99.86% of US companies in our set. 2020-08-18 · Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

..Playstation 5 kostar 5990 kronor i Sverige o

The high price target for AUPH is $35.00 and the low price target for AUPH is $20.00.

Over the past year the S&P 500 has risen 76.23% while AUPH has risen 3.05%. AUPH lost -$0.60 per share the over the last 12 months. Click Here to get the full report on Aurinia Pharmaceuticals Inc (AUPH) Stock. AUPH's price/sales ratio is 32.17; that's higher than the P/S ratio of 92.66% of US stocks. As for revenue growth, note that AUPH's revenue has grown 15,660.38% over the past 12 months; that beats the revenue growth of 99.86% of US companies in our set. 2020-08-18 · Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Aurinia Pharmaceuticals to Present at the SVB Leerink 10th Annual Global Healthcare Conference Business Wire - 2/18/2021 6:05:00 AM: Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021 Business Wire - 2/17/2021 6:05:00 AM Target Price: 11.50: Perf Year-13.75%: Cash/sh-P/C-EPS next 5Y-ROE-52W Range: 12.01 - 20.50: Perf YTD-7.45%: Dividend-P/FCF-EPS past 5Y-ROI-52W High-37.56%: Beta-Dividend %-Quick Ratio-Sales past 5Y-Gross Margin-52W Low: 6.58%: ATR: 0.53: Employees: 294: Current Ratio-Sales Q/Q: 172417.20%: Oper.